SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Renewed Bitcoin and crypto momentum, enthusiasm over Robinhood Chain and tokenized trading, and speculation around a teased product launch are driving attention. Traders largely view these developments as potential boosts to crypto activity and revenue, while others remain skeptical about valuation and continued selling pressure.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields and increased expectations for a Federal Reserve rate hike are the dominant focus, with traders also citing higher oil prices and escalating Iran tensions as pressure on equities. The community is split between bears anticipating a broader pullback and bulls arguing that dip buying, AI strength, and persistent end-of-session rallies are keeping SPY resilient despite the macro risks.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzles quarterly earnings beat and raised full-year guidance have drawn attention, but the stock sold off sharply as traders focused on slower second-half growth, margin compression, higher credit-loss provisions, and its elevated valuation. The community is split between bulls calling the reaction an overdone buying opportunity and bears expecting further repricing after profit-taking and cautious outlook concerns.

Anthropic

Anthropics confidential SEC filing for a potential IPO has made the company a focal point of the AI public-markets race, with traders debating pre-IPO proxy exposure and whether its rapid growth justifies a mega-listing. Bullish enthusiasm over Claudes enterprise adoption and infrastructure expansion is offset by concerns about lofty valuations, heavy capital needs, circular financing, and a potential post-IPO selloff.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

A strong Q2 earnings beat and raised full-year outlook, supported by resilient travel demand and World Cup-related bookings, have fueled a sharp breakout and renewed interest in Airbnbs AI and broader travel-services expansion. Traders remain divided, with bullish momentum and analyst optimism countered by concerns about valuation, overbought conditions, insider selling, regulation, and host attrition.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Bitcoins rally and Strives continued accumulation of BTC through its SATA preferred-stock financing have fueled attention, with traders treating ASST as a high-beta Bitcoin treasury proxy and favorably comparing its performance with larger peers. The community is broadly bullish, though short-squeeze expectations remain speculative and some traders warn that future share issuance could dilute holders.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Attention is centered on Algorands Robinhood availability and its post-quantum technology push, including the v5 mainnet upgrade and quantum-resistant accounts. Bulls view broader exchange access, agentic-payment activity, and potential altcoin-market rotation as supportive, while bears point to weak price performance, dilution concerns, and limited network revenue.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Panasonic Advanced Technologys announced collaboration with Jasmy and JANCTION on a distributed-GPU Smart Render product is driving attention, with traders highlighting reported real-world trials, commercialization plans, and faster 3D/video rendering. Bulls view it as evidence of expanding utility and are celebrating the tokens rebound, while bears question direct token demand, liquidity, and ongoing delisting concerns.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

A rebound and perceived relative strength versus Bitcoin have put Bitcoin Cash in focus, with traders watching for a technical breakout as rising volume, higher lows, accumulation, and possible short covering support the bullish case. Others argue momentum is weak and the breakout may fail, citing BCHs limited usage, underperformance, and the broader crypto downtrend.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Hawkish Federal Reserve commentary and rising Treasury yields have lifted expectations for a possible rate hike, pressuring rate-sensitive small caps and driving bearish IWM put activity. Traders remain divided, with some citing technical support and potential rebounds while others expect further downside as higher borrowing costs weigh on the Russell 2000.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aura Biosciences (NASDAQ:AURA) Sees Large Volume Increase - Here's What Happened

Aura Biosciences (NASDAQ:AURA) Sees Unusually-High Trading Volume - Here's What Happened...

Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 results, cuts FY guidance. Other stocks also down.read more...

HC Wainwright Has Negative Forecast for AURA FY2030 Earnings

Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) - Equities research analysts at HC Wainwright decreased their FY2030 earnings per share estimates for Aura Biosciences in a note issued to investors on Wednesday, April 29th. HC Wainwright analyst A. Maldonado now forecasts that the company will ear...

Levin Capital Strategies L.P. Sells 591,688 Shares of Aura Biosciences, Inc. $AURA

Levin Capital Strategies L.P. trimmed its stake in Aura Biosciences, Inc. (NASDAQ:AURA - Free Report) by 36.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,035,586 shares of the company's stock after sel...

Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) was the recipient of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totaling 2,013,075 shares, a decrease of 23.0% from the March 31st total of 2,615,841 shares. Currently, 3.3% of...

Are Medical Stocks Lagging  Aura Biosciences (AURA) This Year?

Here is how Aura Biosciences, Inc. (AURA) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

Does Aura Biosciences (AURA) Have the Potential to Rally 179.84% as Wall Street Analysts Expect?

The consensus price target hints at a 179.8% upside potential for Aura Biosciences (AURA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Aura Biosciences (NASDAQ:AURA) Insider Sells $82,400.76 in Stock

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Conor Kilroy sold 11,738 shares of the business's stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an average price of $7.02, for a total value of $82,400.76. Following the sale, the insider owned...

Conor Kilroy Sells 11,738 Shares of Aura Biosciences (NASDAQ:AURA) Stock

Aura Biosciences, Inc. (NASDAQ:AURA - Get Free Report) insider Conor Kilroy sold 11,738 shares of the business's stock in a transaction on Thursday, April 16th. The shares were sold at an average...

Aura Biosciences, Inc. (AURA) Just Flashed Golden Cross Signal: Do You Buy?

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.

Aura Biosciences Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.37	--	--	N/A
Q2 '26	-$0.38	-$0.48	-28.00%	MISSED
Q1 '26	-$0.40	-$0.50	-25.79%	MISSED
Q4 '25	-$0.43	-$0.34	20.58%	BEAT
Q3 '25	-$0.46	-$0.40	13.79%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings